Cargando…

An innovative plasmacytoid dendritic cell line-based cancer vaccine primes and expands antitumor T-cells in melanoma patients in a first-in-human trial

The efficacy of immune checkpoint inhibitors has been shown to depend on preexisting antitumor immunity; thus, their combination with cancer vaccines is an attractive therapeutic approach. Plasmacytoid dendritic cells (PDC) are strong inducers of antitumor responses and represent promising vaccine c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Charles, Julie, Chaperot, Laurence, Hannani, Dalil, Bruder Costa, Juliana, Templier, Isabelle, Trabelsi, Sabiha, Gil, Hugo, Moisan, Anaick, Persoons, Virginie, Hegelhofer, Harald, Schir, Edith, Quesada, Jean-Louis, Mendoza, Christophe, Aspord, Caroline, Manches, Olivier, Coulie, Pierre G., Khammari, Amir, Dreno, Brigitte, Leccia, Marie-Thérèse, Plumas, Joel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153838/ https://www.ncbi.nlm.nih.gov/pubmed/32313721 http://dx.doi.org/10.1080/2162402X.2020.1738812

Ejemplares similares

A Novel Cancer Vaccine Strategy Based on HLA-A*0201 Matched Allogeneic Plasmacytoid Dendritic Cells
por: Aspord, Caroline, et al.
Publicado: (2010)

Melanoma hijacks plasmacytoid dendritic cells to promote its own progression
por: Aspord, Caroline, et al.
Publicado: (2014)

Photopheresis efficacy in the treatment of rheumatoid arthritis: a pre-clinical proof of concept
por: Coppard, Céline, et al.
Publicado: (2019)

Engineering a Human Plasmacytoid Dendritic Cell-Based Vaccine to Prime and Expand Multispecific Viral and Tumor Antigen-Specific T-Cells
por: Lenogue, Kevin, et al.
Publicado: (2021)

A New Plasmacytoid Dendritic Cell-Based Vaccine in Combination with Anti-PD-1 Expands the Tumor-Specific CD8+ T Cells of Lung Cancer Patients
por: Hannani, Dalil, et al.
Publicado: (2023)

Plasmacytoid Dendritic Cells Capture and Cross-Present Viral Antigens from Influenza-Virus Exposed Cells
por: Lui, Gabrielle, et al.
Publicado: (2009)

Leveraging a powerful allogeneic dendritic cell line towards neoantigen-based cancer vaccines
por: Hannani, Dalil, et al.
Publicado: (2023)

P16-52. HIV-activated human plasmacytoid DCs induce Tregs through an indoleamine 2,3-dioxygenase-dependent mechanism
por: Manches, O, et al.
Publicado: (2009)

Stimulation of the immune system by a tumor antigen-bearing adenovirus-inspired VLP allows control of melanoma growth
por: Besson, Solène, et al.
Publicado: (2022)

HIV triggers immunoregulatory dendritic cells and regulatory T cells through the non-canonical NF-kB pathway
por: Manches, O, et al.
Publicado: (2012)

Impaired Antitumor Immune Response in MYCN-amplified Neuroblastoma Is Associated with Lack of CCL2 Secretion and Poor Dendritic Cell Recruitment
por: Kacher, Jamila, et al.
Publicado: (2022)

Highly efficient transduction of human plasmacytoid dendritic cells without phenotypic and functional maturation
por: Veron, Philippe, et al.
Publicado: (2009)

Potent Bidirectional Cross-Talk Between Plasmacytoid Dendritic Cells and γδT Cells Through BTN3A, Type I/II IFNs and Immune Checkpoints
por: Girard, Pauline, et al.
Publicado: (2020)

Characterization of species-specific genes regulated by E2-2 in human plasmacytoid dendritic cells
por: Cheng, Menglan, et al.
Publicado: (2015)

NFATC3 promotes IRF7 transcriptional activity in plasmacytoid dendritic cells
por: Bao, Musheng, et al.
Publicado: (2016)

Death receptor 6 is a novel plasmacytoid dendritic cell-specific receptor and modulates type I interferon production
por: Li, Jingyun, et al.
Publicado: (2016)

Long-term response of vulvar mucosal melanoma treated with neoadjuvant nivolumab
por: Dubus, Margaux, et al.
Publicado: (2023)

The dual effect of mesenchymal stem cells on tumour growth and tumour angiogenesis
por: Kéramidas, Michelle, et al.
Publicado: (2013)

The MEK1/2-ERK Pathway Inhibits Type I IFN Production in Plasmacytoid Dendritic Cells
por: Janovec, Vaclav, et al.
Publicado: (2018)

Extracorporeal Photopheresis: Tolerogenic or Immunogenic Cell Death? Beyond Current Dogma
por: Hannani, Dalil
Publicado: (2015)

Multi-organ failure induced by Nivolumab in the context of allo-stem cell transplantation
por: Charles, Julie, et al.
Publicado: (2019)

Diversification of circulating and tumor‐infiltrating plasmacytoid DCs towards the P3 (CD80(+) PDL1(−))‐pDC subset negatively correlated with clinical outcomes in melanoma patients
por: Sosa Cuevas, Eleonora, et al.
Publicado: (2022)

Engelures au cours de la première vague année de la pandémie de COVID-19 : étude observationnelle de 63 patients au centre hospitalier universitaire Grenoble-Alpes
por: Dubus, M., et al.
Publicado: (2022)

Plasma Circulating Tumor DNA Levels for the Monitoring of Melanoma Patients: Landscape of Available Technologies and Clinical Applications
por: Busser, Benoit, et al.
Publicado: (2017)

Dual Role of the Tyrosine Kinase Syk in Regulation of Toll-Like Receptor Signaling in Plasmacytoid Dendritic Cells
por: Aouar, Besma, et al.
Publicado: (2016)

Exploration of the Lysis Mechanisms of Leukaemic Blasts by Chimaeric T-Cells
por: Laurin, David, et al.
Publicado: (2010)

BDCA1(+) cDC2s, BDCA2(+) pDCs and BDCA3(+) cDC1s reveal distinct pathophysiologic features and impact on clinical outcomes in melanoma patients
por: Sosa Cuevas, Eleonora, et al.
Publicado: (2020)

Dysfunctional BTN3A together with deregulated immune checkpoints and type I/II IFN dictate defective interplay between pDCs and γδ T cells in melanoma patients, which impacts clinical outcomes
por: Girard, Pauline, et al.
Publicado: (2021)

Acneiform Lesions but not Acne after Treatment with Janus Kinase Inhibitors: Diagnosis and Management of Janus Kinase-acne
por: BALLANGER, Fabienne, et al.
Publicado: (2023)

Immunothérapie dans le mélanome en hospitalisation à domicile : enquête de satisfaction et retour d’expérience des centres français d’oncodermatologie
por: Truong, Thao, et al.
Publicado: (2021)

CD4 Receptor is a Key Determinant of Divergent HIV-1 Sensing by Plasmacytoid Dendritic Cells
por: O’Brien, Meagan, et al.
Publicado: (2016)

MELOE-1 Antigen Contains Multiple HLA Class II T Cell Epitopes Recognized by Th1 CD4+ T Cells from Melanoma Patients
por: Bobinet, Mathilde, et al.
Publicado: (2012)

PD-1 expression conditions T cell avidity within an antigen-specific repertoire
por: Simon, Sylvain, et al.
Publicado: (2015)

Remodeling of B-Cell Subsets in Blood during Pegylated IFNα-2a Therapy in Patients with Chronic Hepatitis B Infection
por: Aspord, Caroline, et al.
Publicado: (2016)

Pegylated Interferon α-2a Triggers NK-Cell Functionality and Specific T-Cell Responses in Patients with Chronic HBV Infection without HBsAg Seroconversion
por: Bruder Costa, Juliana, et al.
Publicado: (2016)

Inulin Prebiotic Protects against Lethal Pseudomonas aeruginosa Acute Infection via γδ T Cell Activation
por: Boucher, Emilie, et al.
Publicado: (2023)

The Skin Microbiome: A New Actor in Inflammatory Acne
por: Dréno, Brigitte, et al.
Publicado: (2020)

MELOE-1 is a new antigen overexpressed in melanomas and involved in adoptive T cell transfer efficiency
por: Godet, Yann, et al.
Publicado: (2008)

Double Positive CD4CD8 αβ T Cells: A New Tumor-Reactive Population in Human Melanomas
por: Desfrançois, Juliette, et al.
Publicado: (2010)

Microbiota-Derived Extracellular Vesicles Detected in Human Blood from Healthy Donors
por: Schaack, Béatrice, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_drf4o0p4hu8udrf17ocj5d9tve